Roosterbio Inc.

Roosterbio Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and exosome/extracellular vesicle (EV) product and process development to fuel the rapid implementation of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type II Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under one year. RoosterBio is driven by our client's success and creating a world where safe and effective advanced therapies are rapidly developed and widely available on a global scale.

Company Details

Employees
56
Founded
-
Address
5295 Westview Dr, Frederick,maryland,united States
Phone
301-678-9497
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Frederick, Maryland
Looking for a particular Roosterbio Inc. employee's phone or email?

Roosterbio Inc. Questions

News

RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01 - PRWeb

RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01 PRWeb

Nikon CeLL Innovation Enters into a Strategic License Agreement with RoosterBio, a US Company, to Enable GCTP/GMP Manufacturing Platform of Human Mesenchymal Stem Cells and Extracellular Vesicle in Japan - PR Newswire

Nikon CeLL Innovation Enters into a Strategic License Agreement with RoosterBio, a US Company, to Enable GCTP/GMP Manufacturing Platform of Human Mesenchymal Stem Cells and Extracellular Vesicle in Japan PR Newswire

RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing - BioInformant

RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing BioInformant

RoosterBio Appoints Timothy M. Kelly as CEO - I95 Business

RoosterBio Appoints Timothy M. Kelly as CEO I95 Business

RoosterBio and Thermo Fisher Scientific Agree to Collaborate to Advance Cell and Exosome Therapy Manufacturing - Genetic Engineering and Biotechnology News

RoosterBio and Thermo Fisher Scientific Agree to Collaborate to Advance Cell and Exosome Therapy Manufacturing Genetic Engineering and Biotechnology News

Best Practices in MSC Culture: Tracking and Reporting Cellular Age Using Population Doubling Level (PDL) - BioInformant

Best Practices in MSC Culture: Tracking and Reporting Cellular Age Using Population Doubling Level (PDL) BioInformant

RoosterBio announces collaboration with Thermo Fisher to advance cell therapy manufacturing - BioSpectrum Asia

RoosterBio announces collaboration with Thermo Fisher to advance cell therapy manufacturing BioSpectrum Asia

Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities - ScienceDirect.com

Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities ScienceDirect.com

Nikon CeLL Innovation partners with RoosterBio for manufacturing human stem cells and extracellular vesicle in Japan - BioSpectrum Asia

Nikon CeLL Innovation partners with RoosterBio for manufacturing human stem cells and extracellular vesicle in Japan BioSpectrum Asia

RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies - BioInformant

RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies BioInformant

ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102 for Rare Diseases and Cancer - BioInformant

ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102 for Rare Diseases and Cancer BioInformant

FUJIFILM Diosynth Biotechnologies & RoosterBio Announce Collaboration to Enable GMP Manufacturing of Cell & Exosome Therapies - BioInformant

FUJIFILM Diosynth Biotechnologies & RoosterBio Announce Collaboration to Enable GMP Manufacturing of Cell & Exosome Therapies BioInformant

RoosterBio and Tissue Regeneration Therapeutics Collaborate on Human Umbilical Cord-Derived MSC Bioprocess Systems - BioInformant

RoosterBio and Tissue Regeneration Therapeutics Collaborate on Human Umbilical Cord-Derived MSC Bioprocess Systems BioInformant

Sartorius collaborates with RoosterBio to advance downstream purification processes for the manufacture of exosomes - BioInformant

Sartorius collaborates with RoosterBio to advance downstream purification processes for the manufacture of exosomes BioInformant

New Xeno-free Cell Culture Media Product Developed to Accelerate Manufacturing and Commercialization of Adult Stem Cell Products - BioInformant

New Xeno-free Cell Culture Media Product Developed to Accelerate Manufacturing and Commercialization of Adult Stem Cell Products BioInformant

The Emerging Role of Exosome Therapeutics in 2026 - BioInformant

The Emerging Role of Exosome Therapeutics in 2026 BioInformant

Peak MSC—Are We There Yet? - Frontiers

Peak MSC—Are We There Yet? Frontiers

Differences in Adipose- and Bone Marrow-Derived hMSCs - BioInformant

Differences in Adipose- and Bone Marrow-Derived hMSCs BioInformant

Partnership to Ensure Gene-modified Cell Therapies for Ovarian Cancer Trials - Ovarian Cancer News Today

Partnership to Ensure Gene-modified Cell Therapies for Ovarian Cancer Trials Ovarian Cancer News Today

The Need for Adherent Cell Manufacturing: Production Platform and Media Strategies Drive Cell Production Economics - BioProcess International

The Need for Adherent Cell Manufacturing: Production Platform and Media Strategies Drive Cell Production Economics BioProcess International

Fledgling Steps toward Regenerative Medicine Superpowers - Genetic Engineering and Biotechnology News

Fledgling Steps toward Regenerative Medicine Superpowers Genetic Engineering and Biotechnology News

Emma Burman wins Roosterbio Development Award - University College London

Emma Burman wins Roosterbio Development Award University College London

Sartorius & RoosterBio to advance downstream purification for exosomes manufacturing - BioSpectrum India

Sartorius & RoosterBio to advance downstream purification for exosomes manufacturing BioSpectrum India

Top Roosterbio Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant